EE200200318A - Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena - Google Patents

Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena

Info

Publication number: EE200200318A
Authority: EE; Estonia
Prior art keywords: benzazole derivatives; jnk modulators; jnk; modulators; benzazole
Prior art date: 1999-12-24

Application number

EEP200200318A

Other languages

English (en)

Inventor

Halazy Serge

Church Dennis

Camps Montserrat

Gaillard Pascale

Gotteland Jean-Pierre

Original Assignee

Applied Research Systems Ars Holding N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-24

Filing date

2000-12-20

Publication date

2003-10-15

2000-12-20 Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.

2003-10-15 Publication of EE200200318A publication Critical patent/EE200200318A/et

2011-08-15 Publication of EE05456B1 publication Critical patent/EE05456B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Immunology (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200200318A 1999-12-24 2000-12-20 Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena EE05456B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99811207A EP1110957A1 (en)	1999-12-24	1999-12-24	Benzazole derivatives and their use as JNK modulators
PCT/EP2000/013006 WO2001047920A1 (en)	1999-12-24	2000-12-20	Benzazole derivatives and their use as jnk modulators

Publications (2)

Publication Number	Publication Date
EE200200318A true EE200200318A (et)	2003-10-15
EE05456B1 EE05456B1 (et)	2011-08-15

Family

ID=8243214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200318A EE05456B1 (et)	1999-12-24	2000-12-20	Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena

Country Status (32)

Country	Link
US (2)	US7259162B2 (et)
EP (2)	EP1110957A1 (et)
JP (1)	JP4782344B2 (et)
KR (2)	KR100736012B1 (et)
CN (1)	CN1252067C (et)
AR (1)	AR029215A1 (et)
AT (1)	ATE254123T1 (et)
AU (1)	AU780241B2 (et)
BG (1)	BG65986B1 (et)
BR (1)	BR0016911A (et)
CA (1)	CA2394809C (et)
CZ (1)	CZ300984B6 (et)
DE (1)	DE60006580T2 (et)
DK (1)	DK1240164T3 (et)
EA (1)	EA007152B1 (et)
EE (1)	EE05456B1 (et)
ES (1)	ES2206351T3 (et)
HR (1)	HRP20020496B1 (et)
HU (1)	HU229625B1 (et)
IL (2)	IL150346A0 (et)
MX (1)	MXPA02006242A (et)
NO (1)	NO323146B1 (et)
NZ (1)	NZ519423A (et)
PL (1)	PL356634A1 (et)
PT (1)	PT1240164E (et)
RS (1)	RS51008B (et)
SI (1)	SI1240164T1 (et)
SK (1)	SK287546B6 (et)
TR (2)	TR200201509T2 (et)
UA (1)	UA73151C2 (et)
WO (1)	WO2001047920A1 (et)
ZA (1)	ZA200204427B (et)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6982274B2 (en)	2001-04-16	2006-01-03	Eisai Co., Ltd.	1H-indazole compound
US7683078B2 (en)	2001-07-23	2010-03-23	Laboratoires Serono S.A.	Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK's) inhibitors
DE60215042T2 (de) *	2001-12-07	2007-10-04	Applied Research Systems Ars Holding N.V.	Benzazole derivate zur behandlung von scleroderma
CN1310911C (zh) *	2002-04-25	2007-04-18	应用研究系统Ars股份公司	作为脑缺血性疾病和cns疾病治疗剂的哌嗪苯并噻唑
KR20050004214A (ko)	2002-05-31	2005-01-12	에자이 가부시키가이샤	피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
WO2003106455A1 (en) *	2002-06-14	2003-12-24	Applied Research Systems Ars Holding N.V.	Azole methylidene cyanide derivatives and their use as protein kinase modulators
EP2527468B1 (en)	2002-10-23	2014-10-01	University of Utah Research Foundation	Amplicon melting analysis with saturation dyes
JP4885709B2 (ja) *	2003-05-08	2012-02-29	メルクセローノソシエテアノニム	ピリジニルアセトニトリル類
ATE378047T1 (de) *	2003-09-12	2007-11-15	Serono Lab	Benzothiazol-derivate zur behandlung von diabetes
AU2004272307A1 (en) *	2003-09-12	2005-03-24	Merck Serono Sa	Benzoxazole acetonitriles
AU2004272306A1 (en) *	2003-09-12	2005-03-24	Merck Serono Sa	Benzimidazole acetonitriles
CA2561907A1 (en) *	2004-04-08	2005-10-20	Applied Research Systems Ars Holding N.V.	Composition comprising a jnk inhibitor and cyclosporin
US7387887B2 (en) *	2004-04-20	2008-06-17	University Of Utah Research Foundation	Nucleic acid melting analysis with saturation dyes
US9657347B2 (en)	2004-04-20	2017-05-23	University of Utah Research Foundation and BioFire Defense, LLC	Nucleic acid melting analysis with saturation dyes
US7803824B2 (en)	2004-10-29	2010-09-28	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US20060094753A1 (en)	2004-10-29	2006-05-04	Alcon, Inc.	Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
JP5144271B2 (ja) *	2004-11-17	2013-02-13	アレストレーディングソシエテアノニム	ベンゾチアゾ−ル製剤、及びそれらの使用
US7838522B2 (en)	2004-11-17	2010-11-23	Ares Trading S.A.	Benzothiazole formulations and use thereof
PT1828160E (pt)	2004-12-21	2012-01-05	Merck Serono Sa	Derivados cíclicos de sulfonilamino e sua utilização
CN101208320B (zh)	2005-01-31	2012-01-11	默克雪兰诺有限公司	N-羟基酰胺衍生物及其用途
US20060223807A1 (en) *	2005-03-29	2006-10-05	University Of Massachusetts Medical School, A Massachusetts Corporation	Therapeutic methods for type I diabetes
KR20080044836A (ko)	2005-07-15	2008-05-21	라보라뚜와르 세로노 에스. 에이.	자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) *	2005-07-15	2010-12-14	Serono Lab	inibidores de jnk para o tratamento de endometriose
EP1933860A2 (en)	2005-09-01	2008-06-25	Ares Trading S.A.	Treatment of optic neuritis
KR20080097190A (ko)	2005-12-29	2008-11-04	안트로제네시스 코포레이션	태반 줄기세포의 수집과 보존을 위한 개선된 조성물과 이조성물의 이용 방법
EP2026802A2 (en) *	2006-06-02	2009-02-25	Laboratoires Serono SA	Jnk inhibitors for treatment of skin diseases
EP2057004B1 (en) *	2006-08-28	2015-12-23	Dantherm Air Handling A/S	Method for manufacturing a heat exchanger
CA2677679A1 (en)	2007-02-12	2008-08-21	Anthrogenesis Corporation	Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
US20120108585A1 (en) *	2008-08-12	2012-05-03	Sirtris Pharmaceuticals, Inc.	Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
US8129396B2 (en) *	2008-09-29	2012-03-06	Telik, Inc.	2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
AR093183A1 (es)	2010-12-31	2015-05-27	Anthrogenesis Corp	Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
CN102199147A (zh) *	2011-03-19	2011-09-28	陕西合成药业有限公司	用于治疗的硝基咪唑衍生物
AU2012262273B2 (en)	2011-06-01	2017-09-14	Celularity Inc.	Treatment of pain using placental stem cells
CN104903331A (zh) *	2013-01-24	2015-09-09	山东亨利医药科技有限责任公司	Jnk抑制剂
AU2014368925A1 (en) *	2013-12-20	2016-07-21	Biomed Valley Discoveries, Inc.	Cancer treatments using combinations of MEK type I and ERK inhibitors
KR101520378B1 (ko) *	2014-10-02	2015-05-26	(주)에프테크	습식 가스 스크러버의 배기유도장치
WO2016055517A1 (en) *	2014-10-08	2016-04-14	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Novel aminopyridine compounds useful as inhibitors of protein prenylation
JP6886165B2 (ja) *	2016-02-15	2021-06-16	国立大学法人山形大学	ガン抑制薬及び抗腫瘍剤、腫瘍再発防止剤、腫瘍発生予防剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2918369A (en) *	1956-06-15	1959-12-22	Gen Aniline & Film Corp	Non-ionic benzimidazole cyanine dyes containing in alpha-position a cyano group on the methenyl chain
GB864131A (en) *	1957-07-17	1961-03-29	Ciba Ltd	Benzimidazolyl-acetic acid derivatives
DE1963542A1 (de)	1969-12-18	1971-06-24	Siemens Ag	Koppelfeldanordnung fuer Fernmelde-,insbesondere Fernsprechanlagen
JPS51123223A (en) *	1975-04-21	1976-10-27	Fuji Photo Film Co Ltd	Process for producing condensation products
CH593954A5 (et)	1975-07-21	1977-12-30	Ciba Geigy Ag
EP0364765A3 (de) *	1988-10-08	1991-07-17	Bayer Ag	Substituierte 1,3,5-Triazintrione, Verfahren zu ihrer Herstellung und ihre Verwendung gegen parasitäre Protozoen
US4933341A (en) *	1988-10-08	1990-06-12	Bayer Aktiengesellschaft	Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
US5523312A (en) *	1994-09-27	1996-06-04	Sterling Winthrop Inc.	Antipicornaviral agents
US6043083A (en)	1997-04-28	2000-03-28	Davis; Roger J.	Inhibitors of the JNK signal transduction pathway and methods of use
JP4153574B2 (ja) *	1997-09-10	2008-09-24	トーアエイヨー株式会社	新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
GB9721437D0 (en) *	1997-10-10	1997-12-10	Glaxo Group Ltd	Heteroaromatic compounds and their use in medicine

1999
- 1999-12-24 EP EP99811207A patent/EP1110957A1/en not_active Withdrawn
2000
- 2000-12-20 TR TR2002/01509T patent/TR200201509T2/xx unknown
- 2000-12-20 BR BR0016911-0A patent/BR0016911A/pt not_active Application Discontinuation
- 2000-12-20 HU HU0204557A patent/HU229625B1/hu not_active IP Right Cessation
- 2000-12-20 KR KR1020027007971A patent/KR100736012B1/ko not_active Expired - Fee Related
- 2000-12-20 ES ES00991229T patent/ES2206351T3/es not_active Expired - Lifetime
- 2000-12-20 IL IL15034600A patent/IL150346A0/xx unknown
- 2000-12-20 SI SI200030254T patent/SI1240164T1/xx unknown
- 2000-12-20 KR KR1020077008852A patent/KR20070047853A/ko not_active Ceased
- 2000-12-20 SK SK898-2002A patent/SK287546B6/sk not_active IP Right Cessation
- 2000-12-20 CA CA2394809A patent/CA2394809C/en not_active Expired - Lifetime
- 2000-12-20 RS YUP-492/02A patent/RS51008B/sr unknown
- 2000-12-20 AU AU31616/01A patent/AU780241B2/en not_active Expired
- 2000-12-20 DK DK00991229T patent/DK1240164T3/da active
- 2000-12-20 CZ CZ20022169A patent/CZ300984B6/cs not_active IP Right Cessation
- 2000-12-20 HR HR20020496A patent/HRP20020496B1/xx not_active IP Right Cessation
- 2000-12-20 WO PCT/EP2000/013006 patent/WO2001047920A1/en not_active Ceased
- 2000-12-20 NZ NZ519423A patent/NZ519423A/en not_active IP Right Cessation
- 2000-12-20 EP EP00991229A patent/EP1240164B1/en not_active Expired - Lifetime
- 2000-12-20 CN CNB008187045A patent/CN1252067C/zh not_active Expired - Lifetime
- 2000-12-20 EE EEP200200318A patent/EE05456B1/et not_active IP Right Cessation
- 2000-12-20 JP JP2001549390A patent/JP4782344B2/ja not_active Expired - Lifetime
- 2000-12-20 TR TR2003/02320T patent/TR200302320T4/xx unknown
- 2000-12-20 US US10/168,718 patent/US7259162B2/en not_active Expired - Lifetime
- 2000-12-20 AT AT00991229T patent/ATE254123T1/de active
- 2000-12-20 PT PT00991229T patent/PT1240164E/pt unknown
- 2000-12-20 MX MXPA02006242A patent/MXPA02006242A/es active IP Right Grant
- 2000-12-20 PL PL00356634A patent/PL356634A1/xx unknown
- 2000-12-20 EA EA200200708A patent/EA007152B1/ru not_active IP Right Cessation
- 2000-12-20 DE DE60006580T patent/DE60006580T2/de not_active Expired - Lifetime
- 2000-12-20 UA UA2002065195A patent/UA73151C2/uk unknown
- 2000-12-22 AR ARP000106912A patent/AR029215A1/es active IP Right Grant
2002
- 2002-06-03 ZA ZA200204427A patent/ZA200204427B/en unknown
- 2002-06-18 BG BG106830A patent/BG65986B1/bg unknown
- 2002-06-20 IL IL150346A patent/IL150346A/en not_active IP Right Cessation
- 2002-06-21 NO NO20022997A patent/NO323146B1/no not_active IP Right Cessation
2007
- 2007-07-18 US US11/779,585 patent/US7470686B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20030162794A1 (en)	2003-08-28
SI1240164T1 (en)	2004-04-30
ATE254123T1 (de)	2003-11-15
CA2394809C (en)	2011-03-15
TR200302320T4 (tr)	2004-01-21
KR20020072282A (ko)	2002-09-14
AR029215A1 (es)	2003-06-18
IL150346A (en)	2010-12-30
CA2394809A1 (en)	2001-07-05
EP1240164B1 (en)	2003-11-12
US7470686B2 (en)	2008-12-30
PT1240164E (pt)	2004-02-27
CN1252067C (zh)	2006-04-19
EA007152B1 (ru)	2006-08-25
US20070259892A1 (en)	2007-11-08
HU229625B1 (hu)	2014-03-28
EP1240164A1 (en)	2002-09-18
HUP0204557A2 (en)	2003-05-28
HRP20020496B1 (hr)	2009-03-31
HK1055730A1 (en)	2004-01-21
CZ300984B6 (cs)	2009-09-30
BR0016911A (pt)	2002-10-22
DE60006580D1 (de)	2003-12-18
ZA200204427B (en)	2004-02-03
WO2001047920A1 (en)	2001-07-05
HRP20020496A2 (en)	2006-03-31
YU49202A (sh)	2006-01-16
BG106830A (bg)	2003-02-28
US7259162B2 (en)	2007-08-21
DE60006580T2 (de)	2004-09-16
CZ20022169A3 (cs)	2002-09-11
EE05456B1 (et)	2011-08-15
BG65986B1 (bg)	2010-08-31
EA200200708A1 (ru)	2003-02-27
MXPA02006242A (es)	2003-01-28
CN1433414A (zh)	2003-07-30
EP1110957A1 (en)	2001-06-27
NO20022997D0 (no)	2002-06-21
UA73151C2 (en)	2005-06-15
JP4782344B2 (ja)	2011-09-28
NO323146B1 (no)	2007-01-08
DK1240164T3 (da)	2004-03-01
SK8982002A3 (en)	2002-10-08
HUP0204557A3 (en)	2009-03-30
ES2206351T3 (es)	2004-05-16
IL150346A0 (en)	2002-12-01
RS51008B (sr)	2010-10-31
TR200201509T2 (tr)	2002-09-23
JP2003519142A (ja)	2003-06-17
NZ519423A (en)	2004-04-30
KR100736012B1 (ko)	2007-07-06
AU780241B2 (en)	2005-03-10
KR20070047853A (ko)	2007-05-07
SK287546B6 (sk)	2011-01-04
AU3161601A (en)	2001-07-09
PL356634A1 (en)	2004-06-28
NO20022997L (no)	2002-06-21

Publication	Publication Date	Title
EE200200318A (et)	2003-10-15	Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena
EE200200251A (et)	2003-06-16	Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE200200341A (et)	2003-10-15	Asendatud oksasolidinoonid ja nende kasutamine
NO20021400D0 (no)	2002-03-20	Terapeutiske konazolinderivater
DE60031513D1 (de)	2006-12-07	Phenyl- und pyridinyl-derivate verwendbar als neurokinin-1-antagonisten
ID26056A (id)	2000-11-23	Popok sekali pakai
ID26389A (id)	2000-12-21	Popok sekali pakai
DE60010333D1 (de)	2004-06-03	Substituierte oxazole und thiazole derivate als hppar-alpha aktivatore
EE200100403A (et)	2002-10-15	Indooli derivaadid ja nende kasutamine MCP-1 antagonistidena
EE200100373A (et)	2002-10-15	Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
DK1206457T3 (da)	2004-02-16	Biaryl-oxa(thia)zolderivater og deres anvendelse som modulatorer PPAP'ER
DE60020701D1 (de)	2005-07-14	Thiazol- und oxazol-derivate und ihre pharmazeutische verwendung
DE60001107D1 (de)	2003-02-06	Sichere und handliche hinweisanordung
DE60032898D1 (de)	2007-02-22	Arylthiazolidindion- und aryloxazolidinderivate
DE60043058D1 (de)	2009-11-12	Dentalwerkstoffe
ID25571A (id)	2000-10-19	Popok sekali pakai
ID24782A (id)	2000-08-10	Popok sekali pakai
EE200200135A (et)	2003-04-15	D4 antagonistidena toimivad tienoisoksasolüül- jatienüülpürrasolüülfenoksü-asendatud propüülderivaadid
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
NO20001718D0 (no)	2000-04-03	Benzen-fusjonerte heterocykliske derivater og anvendelse derav
IT1310175B1 (it)	2002-02-11	Bruciatore perfezionato
ID30381A (id)	2001-11-29	Penggunaan arilalkanoilpiridazina
EE200200611A (et)	2004-06-15	Antihüpertensiivsed ained ja kasutamine
DE69914937D1 (de)	2004-03-25	Betablocker und carbopol enthaltende ophtalmische zusammensetzung
SE9904414D0 (sv)	1999-12-03	Pharmaceutical composition and use

Legal Events

Date	Code	Title	Description
2007-10-15	GB1A	Change in the ownership or in the address of the owner
2012-04-16	HC1A	Change of owner name
2015-08-17	MM4A	Lapsed by not paying the annual fees	Effective date: 20141220